Dickinson Andrew D — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Dickinson Andrew D has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $27.83M.

Profile

Dickinson Andrew D

Andrew D. Dickinson is the Chief Financial Officer of Gilead Sciences, Inc., where he plays a crucial role in the company's financial strategy and operations. He has been involved in various SEC filings, indicating his active participation in corporate governance and financial reporting.

RoleChief Financial Officer
Notability50/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-16GILDGILEAD SCIENCES, INC.S — Open-market sale3.0K$125.40$376K
2026-06-11GILDGILEAD SCIENCES, INC.F — Tax withholding / forfeiture1.3K$121.48$163K
2026-06-11GILDGILEAD SCIENCES, INC.M — Option exercise2.8K
2026-05-18GILDGILEAD SCIENCES, INC.S — Open-market sale3.0K$132.27$397K
2026-04-16GILDGILEAD SCIENCES, INC.S — Open-market sale3.0K$140.96$423K
2026-03-17GILDGILEAD SCIENCES, INC.S — Open-market sale [10b5-1]3.0K$144.23$433K
2026-03-12GILDGILEAD SCIENCES, INC.F — Tax withholding / forfeiture3.1K$148.56$468K
2026-03-12GILDGILEAD SCIENCES, INC.M — Option exercise6.5K
2026-03-02GILDGILEAD SCIENCES, INC.A — Grant or award11.1K$0.00
2026-02-18GILDGILEAD SCIENCES, INC.S — Open-market sale [10b5-1]3.0K$154.43$463K
2026-02-05GILDGILEAD SCIENCES, INC.F — Tax withholding / forfeiture24.8K$143.28$3.55M
2026-02-05GILDGILEAD SCIENCES, INC.A — Grant or award44.9K$0.00
2026-01-16GILDGILEAD SCIENCES, INC.S — Open-market sale [10b5-1]3.0K$124.31$373K
2025-12-16GILDGILEAD SCIENCES, INC.S — Open-market sale [10b5-1]3.0K$122.00$366K
2025-10-15GILDGILEAD SCIENCES, INC.S — Open-market sale2.5K$118.08$295K
2025-09-15GILDGILEAD SCIENCES, INC.S — Open-market sale2.5K$113.57$284K
2025-09-10GILDGILEAD SCIENCES, INC.F — Tax withholding / forfeiture1.8K$115.25$202K
2025-09-10GILDGILEAD SCIENCES, INC.M — Option exercise3.7K
2025-08-15GILDGILEAD SCIENCES, INC.S — Open-market sale2.5K$118.53$296K
2025-07-15GILDGILEAD SCIENCES, INC.S — Open-market sale2.5K$111.03$278K

Companies — Last 90 Days

Frequently Asked Questions

Who is Dickinson Andrew D?

Andrew D. Dickinson is the Chief Financial Officer of Gilead Sciences, Inc., where he plays a crucial role in the company's financial strategy and operations. He has been involved in various SEC filings, indicating his active participation in corporate governance and financial reporting.…

How many SEC Form 4 filings has Dickinson Andrew D submitted recently?

3 primary Form 4 filings in the last 90 days, covering 1 company.

Has Dickinson Andrew D been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 14 open-market sales ($27.83M) across all tracked filings.

Where can I see all of Dickinson Andrew D's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Dickinson Andrew D profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.